These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11998328)

  • 1. [Secondary prevention of myocardial infarction in the Ile de France].
    Bérigaud E; Silvera L; Du Bron D; Dupont-Zacot E; Chabry C; Trutt B; Blanchon B; Parmentier M; Hecquard P
    Arch Mal Coeur Vaiss; 2002 Mar; 95(3):150-6. PubMed ID: 11998328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary prevention of myocardial infarction in the Basse-Normandie region].
    Pédaillès S; Kühn F; Grollier G; Thielly P
    Arch Mal Coeur Vaiss; 2005 Oct; 98(10):960-5. PubMed ID: 16294540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary prevention after myocardial infarction].
    Bergstrand R; Elmfeldt D; Hjalmarson A; Vedin JA; Wilhelmsen L; Wilhelmsson C
    Lakartidningen; 1978 May; 75(20):2038-44. PubMed ID: 26827
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug prescription in myocardial postinfarction: results of the EPPI (étude de prescription postinfarctus). A French cooperative study].
    Boissel JP; Némoz C; Gillet J; Salewski B; Diaz N
    Arch Mal Coeur Vaiss; 1990 Nov; 83(12):1777-82. PubMed ID: 1980055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug prescription in the postinfarction period; results of the EPPI II (Study of Postinfarct Prescription). A French cooperative study].
    Boissel JP; Némoz C; Leizorovicz A; Gillet J
    Arch Mal Coeur Vaiss; 1995 Sep; 88(9):1261-6. PubMed ID: 8526704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary prevention of the basic risk factors in patients with a history of myocardial infarction].
    Kokutsov A; Petev L
    Vutr Boles; 1990; 29(3):110-6. PubMed ID: 2284791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial infarction--secondary prevention.
    Hjalmarson A
    Acta Med Scand Suppl; 1986; 712():35-9. PubMed ID: 2880462
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heart and brain: are the risk factors the same? Are the results of primary and secondary trials comparable?].
    Castaigne A; Haziza F; Lopes-Darmon ME
    Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():59-63. PubMed ID: 9833081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI)].
    Tebbe U; Messer C; Stammwitz E; The GS; Dietl J; Bischoff KO; Schulten-Baumer U; Tebbenjohanns J; Gohlke H; Bramlage P;
    Dtsch Med Wochenschr; 2007 Jul; 132(30):1559-66. PubMed ID: 17628839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary prevention after myocardial infarction].
    Vacheron A; Bounhoure JP;
    Bull Acad Natl Med; 2007 Nov; 191(8):1763-77. PubMed ID: 18666472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
    Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
    Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME; Bouvy ML; de Blaey CJ; de Boer A
    Clin Ther; 2005 Nov; 27(11):1806-14. PubMed ID: 16368451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [After-care of the patient with myocardial infarct].
    Muntwyler J; Rickli H; Kiowski W; Amann FW
    Praxis (Bern 1994); 1997 Sep; 86(38):1467-70. PubMed ID: 9381048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intervention program to improve secondary prevention of myocardial infarction. Results of the PRESENTE (early secondary prevention) study].
    de Velasco JA; Cosín J; de Oya M; de Teresa E;
    Rev Esp Cardiol; 2004 Feb; 57(2):146-54. PubMed ID: 14967110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of secondary vascular prevention in practice after cerebral ischemia and coronary heart disease.
    Girot M; Deplanque D; Pasquier F; Destée A; Leys D
    J Neurol; 2004 May; 251(5):529-36. PubMed ID: 15164184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of briefly-assessed depression on secondary prevention outcomes after acute coronary syndrome: a one-year longitudinal survey.
    McGee HM; Doyle F; Conroy RM; De La Harpe D; Shelley E
    BMC Health Serv Res; 2006 Feb; 6():9. PubMed ID: 16476160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
    Wachtel TM; Kucia AM; Greenhill JA
    Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.